Core Current Deferred Revenue from 2010 to 2025
| CORZ Stock | USD 7.48 0.40 5.08% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 16.3 M | Current Value 15.5 M | Quarterly Volatility 30.6 M |
Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 811.8 K, Depreciation And Amortization of 71.3 M or Interest Expense of 59.2 M, as well as many indicators such as Price To Sales Ratio of 7.39, Dividend Yield of 0.0 or Days Sales Outstanding of 0.7. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.
Core | Current Deferred Revenue |
Latest Core Scientific,'s Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Core Scientific, Common over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Core Scientific,'s Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Core Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 41,248,823 | |
| Geometric Mean | 33,093,215 | |
| Coefficient Of Variation | 74.22 | |
| Mean Deviation | 17,078,118 | |
| Median | 44,843,000 | |
| Standard Deviation | 30,614,861 | |
| Sample Variance | 937.3T | |
| Range | 132.1M | |
| R-Value | (0.27) | |
| Mean Square Error | 931.2T | |
| R-Squared | 0.07 | |
| Significance | 0.31 | |
| Slope | (1,734,455) | |
| Total Sum of Squares | 14059T |
Core Current Deferred Revenue History
About Core Scientific, Financial Statements
Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 16.3 M | 15.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.